新闻
新闻
- Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
01.09.2021 / 08:01 - GlobeNewswire - Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine
23.08.2021 / 13:45 - GlobeNewswire - Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
23.08.2021 / 07:00 - GlobeNewswire - Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine
09.08.2021 / 07:00 - GlobeNewswire - Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
11.06.2021 / 19:12 - GlobeNewswire - Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human Trial
08.03.2021 / 07:00 - GlobeNewswire - Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
16.12.2020 / 20:51 - GlobeNewswire - Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine
24.08.2020 / 21:22 - GlobeNewswire - Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
22.07.2020 / 08:00 - GlobeNewswire - Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine
01.07.2020 / 15:23 - GlobeNewswire